Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ENROLLING_BY_INVITATION
NA
5 participants
INTERVENTIONAL
2017-02-01
2025-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Investigators will try to identify areas of the brain responsible for processing and storing information about self-facial recognition; Examine how these areas of the brain respond to images of "self" and "non-self" and; Investigate how the brain responds, over time, to changes in facial recognition, particularly at time points: i) prior to facial injury, ii) post-injury but prior to facial transplantation, and iii) after receiving facial transplantation.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Visualization of Neural Targets With 3T MRI
NCT05175417
Anterior Temporal Epilepsy Neuropsychological Assessment of Faces
NCT02888925
fMRI in CardiaC arrEst With Uncertain Prognosis
NCT06423768
Examining Brain Changes Using Functional Magnetic Resonance Imaging (fMRI) in Amputees With Phantom Limb Pain Following Mirror Therapy
NCT00662415
Functional MRI Study of Attention in Normal Controls and Traumatic Brain Injured Patients
NCT00580918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pre-Transplant Time Point
Participants will be imaged in the Magnetic Resonance Imaging scanner (MRI)
Face recognition task
Inside the MRI scanner and during the experiment, participants will be asked to make judgments about the identity they perceived in each morphed picture.
Post-Transplant Time Point
Participants will be imaged in the Magnetic Resonance Imaging scanner (MRI). Patients for whom a pre-transplant fMRI was obtained will undergo functional MRI scanning at three-points post-transplant (approximately 2 and 4 months +/- 2 months post-operation and again at 1 year +/- 3 months post-transplant).
Face recognition task
Inside the MRI scanner and during the experiment, participants will be asked to make judgments about the identity they perceived in each morphed picture.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Face recognition task
Inside the MRI scanner and during the experiment, participants will be asked to make judgments about the identity they perceived in each morphed picture.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Able to give full informed consent, before each scan and throughout their time in which they are participating in the study
* Able to perform the task to a high standard and also to have no underlying conditions that may alter how they process pictures of face
* Participants must have none of the following, which cannot safely be removed without risk or discomfort while they enter the MRI unit:
* a pacemaker
* metal implants
* metal that cannot be removed on their body (e.g. shrapnel, piercings)
* metal clips
* an artificial heart valve
* a cochlear implant
* drug patches
* a contraceptive coil
* dental plates/braces with metal in
* hearing aids
* Participants will also be excluded on the grounds of safety and comfort inside the MRI scanner if they have one of the following underlying conditions
* epilepsy
* diabetes
* heart disease
* thermoregulatory problems (problems regulating body temperature)
* a possibility of being pregnant
* currently breastfeeding
* Participants will also be excluded on the grounds of MRI data quality for the following reasons:
* history of mental illness
* claustrophobia (discomfort in confined spaces)
* Neurological conditions
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
NYU Langone Health
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Eduardo Rodriguez
Role: PRINCIPAL_INVESTIGATOR
NYU Langone Health
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
New York University School of Medicine
New York, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
16-01144
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.